Gender-associated differences in urea breath test for Helicobacter pylori infection referrals and results among dyspeptic patients.

World J Gastrointest Pathophysiol

Menachem Moshkowitz, Noya Horowitz, Zamir Halpern, Erwin Santo, Department of Gastroenterology, Tel-Aviv Sourasky Medical Center, Affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, Israel.

Published: June 2012

Aim: To verify whether there is a gender difference in the (13)C-urea breath test results in a large cohort.

Methods: The test results of dyspeptic patients referred for (13)C-urea breath testing between January and December, 2007 were evaluated. Testing was carried out at the health insurance organization branches and evaluated at a central laboratory in Israel.

Results: Of a total of 28 746 test results, 18 122 (63.04%) were from females and 10 624 (36.95%) from males. Overall, 10 188 (35.4%) results [expressed as delta over baseline (DOB)] were positive (DOB (13)C > 5), 18,326 (63.7%) were negative (DOB (13)C < 3.5) and 232 (0.8%) were borderline (DOB (13)C 3.5-5). There was a significant difference between the total positive rate among females and males (34.8% vs 37.2%, respectively, P = 0.0003). The mean test value was increased by approximately 10 units for females compared to males (P < 0.01) and this difference was consistent for all age groups (i.e., between 10-80 years of age, P < 0.01).

Conclusion: More females were referred to (13)C-urea breath testing. More males had positive results. The mean test values were significantly higher among females of all age groups, possibly representing an increased bacterial load among females and suggesting gender-associated differences in Helicobacter pylori host interactions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382706PMC
http://dx.doi.org/10.4291/wjgp.v3.i3.80DOI Listing

Publication Analysis

Top Keywords

13c-urea breath
12
dob 13c
12
gender-associated differences
8
breath test
8
helicobacter pylori
8
dyspeptic patients
8
referred 13c-urea
8
breath testing
8
age groups
8
test
6

Similar Publications

Innovative nomogram approach to enhance the prediction of Helicobacter pylori infection in children via magnetic-controlled capsule endoscopy.

Eur J Pediatr

January 2025

Department of Digestive Endoscopy Center, School of Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, 200062, China.

Unlabelled: Early detection and intervention are crucial in managing Helicobacter pylori (HP) infections, which are associated with various gastrointestinal diseases in children. The traditional Kyoto gastritis scoring system, though effective, requires adaptation for non-invasive techniques like magnetic-controlled capsule endoscopy to enhance early diagnosis and improve patient comfort. This retrospective study involved 474 pediatric patients who underwent magnetic-controlled capsule endoscopy coupled with a C urea breath test at the Children's Hospital affiliated with Shanghai Jiao Tong University School of Medicine from January to December 2023.

View Article and Find Full Text PDF

Introduction: Previous studies reported inconsistent results of the association between Helicobacter pylori infection and nonalcoholic fatty liver disease (NAFLD).

Methods: A cohort study of 2,063 adults without NAFLD at baseline, who participated in a repeated health checkup including a 13C-urea breath test and abdominal ultrasonography, was conducted to evaluate the link between H. pylori infection and NAFLD development.

View Article and Find Full Text PDF
Article Synopsis
  • Vonoprazan (VPZ) shows better acid-inhibition than proton pump inhibitors (PPIs) but little research has been done on its effectiveness in treating Helicobacter pylori infection with bismuth quadruple therapy (VBQT).* -
  • This study evaluated VBQT's safety and effectiveness in eradicating H pylori in treatment-naive patients over a period from March 2021 to May 2023, involving 612 participants.* -
  • Results indicated high eradication rates of 84.3% to 96.4% across various analyses, with a 12.7% adverse event rate and 96.9% treatment compliance, suggesting VBQT is a promising first-line treatment for
View Article and Find Full Text PDF

Objectives: We started () screening program of students at Juntendo university in 2020. We report the current status of screening program and the outcomes of screening program.

Methods: The students of the School of the Faculty of Health Sciences of Juntendo University enrolling in the spring of 2020-2022 were recruited for this study.

View Article and Find Full Text PDF

Background: The global prevalence of obesity is increasing and represents a major public health challenge. However, there is a paucity of data regarding Helicobacter pylori (H pylori) eradication in people with obesity. The aim of the study is to examine the influence of obesity degree on H.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!